News

Patients with congenital Factor XIII do not make enough Factor XIII, a substance in the blood that is important for normal clotting, and people with this condition are

Simponi (golimumab) is a TNF-alpha blocker. Simponi, typically injected monthly alone or in combination with methotrexate, was approved by the FDA on 24 April 2009 for the treatment

Apart from eyeing OTC brands across vitamins, mineral supplements, orthopaedic, gynaecology and nutraceutical brands, Sanofi Aventis is also looking for brands in anti-infective, antibiotics, respiratory tract infection and

Jantoven (crystalline warfarin sodium) is an anticoagulant which acts by inhibiting vitamin K-dependent coagulation factors. The recall was initiated as a precautionary measure after a single bottle labeled

Eliglustat tartrate is a novel glucosylceramide analog administeredorally, which partially inhibits the enzyme glucosylceramide synthase. Currently, it is being developed to provide a convenient treatment alternative for adult

US Patent No. 7,871,795 encompasses the use of the platform for trans-splicing into highly abundant gene transcripts to produce therapeutic products. US Patent No. 7,879,321 covers the use

Preparations are now underway to launch the product through Global Pharmaceuticals, Impax’s generic division. Adoxa is a tetracycline antibiotic indicated for the treatment of bacterial infections. According to

The programme will enable the Hayes community of physicians across southern Florida, US, to achieve meaningful use compliance and qualify for federal incentive dollars of $44,000 to $63,750

It has also expanded its existing design centers in Chicago, Detroit, Kansas City, Pittsburgh and Juarez, Mexico metropolitan areas. Additionally, xpedx has added new package design staff and